Related Experiment Video

Updated: Jul 24, 2025

Author Spotlight: Epigenetic Modifications and Metabolic Rewiring as Targets for Cancer Therapy
07:20

Author Spotlight: Epigenetic Modifications and Metabolic Rewiring as Targets for Cancer Therapy

Published on: October 18, 2024

567

Histone modifications in drug-resistant cancers: From a cancer stem cell and immune evasion perspective

Ming Li Jin1, Kwang Won Jeong2

  • 1Gachon Research Institute of Pharmaceutical Sciences, College of Pharmacy, Gachon University, 191 Hambakmoero, Yeonsu-gu, Incheon, 21936, Republic of Korea.

Experimental & Molecular Medicine
|July 2, 2023
PubMed

Insights

Restoring abnormal histone modifications can overcome cancer stem cell (CSC) drug resistance and immune evasion. This approach enhances chemotherapy and immunotherapy efficacy by sensitizing CSCs to treatment.

Area of Science:

  • Oncology
  • Epigenetics
  • Immunology

Background:

  • Cancer stem cells (CSCs) drive tumor development, metastasis, and therapy resistance.
  • Epigenetic reprogramming influences CSC marker proteins, plasticity, survival, and immune evasion.
  • Current anticancer therapies are limited by CSCs' ability to evade immune responses.

Purpose of the Study:

  • To review the role of histone modifiers in CSC drug resistance and immune evasion.
  • To explore strategies for restoring dysregulated histone modifications in cancer treatment.
  • To discuss combining histone modification inhibitors with conventional therapies.

Main Methods:

  • Literature review of recent findings on histone modifiers and CSCs.
  • Analysis of CSCs' epigenetic reprogramming and immune evasion mechanisms.
  • Examination of therapeutic strategies targeting histone modifications.

Main Results:

  • Histone modifiers play a crucial role in CSC development and drug resistance.
  • Dysregulated histone modifications contribute to CSC immune evasion.
  • Restoring normal histone modifications can re-sensitize CSCs to therapy.

Conclusions:

  • Targeting histone modifications offers a promising strategy to enhance cancer therapy.
  • Combining histone modification inhibitors with chemotherapy or immunotherapy may improve outcomes.
  • Further research is needed to develop effective histone modifier-based cancer treatments.

More Related Videos

Studying Pancreatic Cancer Stem Cell Characteristics for Developing New Treatment Strategies07:29

Studying Pancreatic Cancer Stem Cell Characteristics for Developing New Treatment Strategies

Published on: June 20, 2015

19.7K
Isolation and Characterization of a Head and Neck Squamous Cell Carcinoma Subpopulation Having Stem Cell Characteristics11:28

Isolation and Characterization of a Head and Neck Squamous Cell Carcinoma Subpopulation Having Stem Cell Characteristics

Published on: May 11, 2016

8.6K

Related Concept Videos

Cancer Stem Cells and Tumor Maintenance02:40

Cancer Stem Cells and Tumor Maintenance

Early diagnosis and treatment can often cure cancer. However, even with treatment, residual cells called cancer stem cells (CSC) might remain, often causing tumor recurrence. These cancer stem cells possess the potential for self-renewal and multi-lineage differentiation and are often responsible for the therapeutic resistance displayed in most cancers.
Cancer stem cells are thought to originate from tissue-specific normal stem cells or progenitor cells. The normal stem cells usually reside in...
5.0K
Treatment Resistant Cancers02:56

Treatment Resistant Cancers

Cancer is the second leading cause of death in the United States. A cancer cell is genetically unstable and hence can mutate faster. They can also modify their microenvironment and escape immune surveillance. The difficulties in treating cancer are further compounded by the emergence of rapid resistance to anticancer drugs. The most common ways to attain resistance in cancer cells include alteration in drug transport and metabolism, modification of drug target, elevated DNA damage response, or...
3.3K
Adaptive Mechanisms in Cancer Cells02:53

Adaptive Mechanisms in Cancer Cells

Cancer cells accumulate genetic changes at an abnormally rapid rate due to the defects in the DNA repair mechanisms. From an evolutionary perspective, such genetic instability is advantageous for cancer development. Mutant cell lines accumulate a series of beneficial mutations that contribute to their progression into cancer.
Some of the advantages that cancer cells have on normal cells include - enhanced ability to divide without terminally differentiating, induce new blood vessel formation,...
5.8K
Metastasis02:30

Metastasis

Metastasis is the spread of cancer cells from the original site to distant locations in the body. Cancer cells can spread via blood vessels (hematogenous) as well as lymph vessels in the body.
Epithelial-to-Mesenchymal Transition
The epithelial-to-mesenchymal transition or EMT is a developmental process commonly observed in wound healing, embryogenesis, and cancer metastasis. EMT is induced by transforming growth factor-beta (TGF-β) or receptor tyrosine kinase (RTK) ligands, which further...
5.6K
Regulation of Hematopoietic Stem Cells01:01

Regulation of Hematopoietic Stem Cells

All blood and immune cells are produced from the multipotent hematopoietic stem cells (HSCs) by the process of hematopoiesis. However, they all have a limited life span. In addition, many are depleted in immune surveillance or combatting an injury or infection. This makes blood one of the most regenerative tissues. Hematopoiesis helps replenish these blood and immune cells, restoring the body's normal functioning. However, overproduction of blood and immune cells can make them cancerous or...
3.2K
Targeted Cancer Therapies02:57

Targeted Cancer Therapies

The targeted cancer therapies, also known as “molecular targeted therapies,” take advantage of the molecular and genetic differences between the cancer cells and the normal cells. It needs a thorough understanding of the cancer cells to develop drugs that can target specific molecular aspects that drive the growth, progression, and spread of cancer cells without affecting the growth and survival of other normal cells in the body.
There are several types of targeted therapies against...
7.7K